Silver Book Fact

A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.

Murphy, Kevin M. and Robert H. Topel. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy, Kevin M. and Robert H. Topel

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine to fight breast cancer is currently in the pipeline. It targets the Bcl-2 protein, which appears to contribute…  
  • Colorectal Cancer Screening: Trends, 2003-2006  
  • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.